Masimo (MASI) Cost of Revenue (2009 - 2026)
Masimo's (MASI) quarterly Cost of Revenue came in at $152.8 million in Q2 2026, up 10.72% year-on-year from $138.0 million in Q2 2025, and down 7.51% quarter-over-quarter from $165.2 million in Q1 2026.
Masimo (MASI) Cost of Revenue (2009 - 2026) Analysis & Trends
Masimo's Cost of Revenue history runs 18 years deep, the most recent figure standing at $152.8 million for Q2 2026.
- On a quarterly basis, Cost of Revenue rose 10.72% year-over-year to $152.8 million in Q2 2026; TTM through Apr 2026 was $596.5 million, a 1.55% decrease from a year earlier, with the FY2026 full-year figure at $581.7 million, down 3.2% from the prior year.
- Cost of Revenue eased to $152.8 million in Q2 2026 per MASI's latest filing, from $165.2 million in the prior quarter.
- Across five years, Cost of Revenue topped out at $307.1 million in Q3 2022 and bottomed at -$248.5 million in Q4 2023.
- The 5-year median for Cost of Revenue is $146.8 million (2025), against an average of $164.5 million.
- Biggest YoY gain for Cost of Revenue was 181.61% in 2023; the steepest drop was 181.85% in 2023.
- Year by year, Cost of Revenue stood at $303.6 million in 2022, then slumped by 181.85% to -$248.5 million in 2023, then soared by 180.52% to $200.1 million in 2024, then fell by 29.59% to $140.9 million in 2025, then grew by 8.45% to $152.8 million in 2026.
- Per Business Quant, the three latest MASI Cost of Revenue figures stand at $152.8 million (Q2 2026), $165.2 million (Q1 2026), and $140.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 4.89 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 2.21 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 3.40 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 12.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 362.60 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 441.60 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 481.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 2.51 Bn |
| 10 | Masimo | 9.39 Bn | 9.27 Bn | 250.80 Mn | 152.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 152.80 Mn |
| Apr 4, 2026 | 152.80 Mn |
| Jan 3, 2026 | 165.20 Mn |
| Jan 3, 2026 | 165.20 Mn |
| Sep 27, 2025 | 140.90 Mn |
| Sep 27, 2025 | 140.90 Mn |
| Jun 28, 2025 | 137.60 Mn |
| Jun 28, 2025 | 137.60 Mn |
| Mar 29, 2025 | 138.00 Mn |
| Mar 29, 2025 | 138.00 Mn |
| Dec 28, 2024 | 200.10 Mn |
| Dec 28, 2024 | 200.10 Mn |
| Sep 28, 2024 | 131.20 Mn |
| Sep 28, 2024 | 131.20 Mn |
| Jun 29, 2024 | 136.60 Mn |
| Jun 29, 2024 | 136.60 Mn |
| Mar 30, 2024 | 133.00 Mn |
| Mar 30, 2024 | 133.00 Mn |
| Dec 30, 2023 | -248.50 Mn |
| Dec 30, 2023 | -248.50 Mn |